Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8744994 | Clinical Microbiology and Infection | 2017 | 24 Pages |
Abstract
Future studies assessing the impact of new AMS strategies should produce compelling evidence by opting for cRCTs, or ITS including a control arm. Furthermore, a holistic view of intended and unintended consequences should be reported, and a detailed process evaluation should be provided to adequately inform implementation of successful AMS strategies to battle the rising burden of AMR.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
M.E.A. de Kraker, M. Abbas, B. Huttner, S. Harbarth,